Atlas Venture Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
APVO | F | Aptevo Therapeutics Inc. | 0.48 | |
BTAI | F | BioXcel Therapeutics, Inc. | -0.96 | |
LPTX | C | LEAP THERAPEUTICS, INC. | -4.01 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BTEC | D | Principal Healthcare Innovators Index ETF | 0.04 | |
IWC | C | iShares Microcap ETF | 0.01 | |
VTWG | C | Vanguard Russell 2000 Growth ETF | 0.0 | |
SCHB | B | Schwab U.S. Broad Market ETF | 0.0 | |
VTI | B | Vanguard Total Stock Market ETF | 0.0 |
Compare ETFs
- Atlas Venture
This article is about the life sciences venture capital firm Atlas Venture, which previously also invested in technology. For the technology team formerly at Atlas Venture, see Accomplice.Atlas Venture is an early-stage venture capital firm that invests in life sciences startup companies in the U.S.. Atlas is headquartered in Cambridge, Massachusetts where the majority of its investments are located.
Atlas rolled out its eleventh biotech fund totaling $350 million in June 2017, after closing its tenth fund in April 2015 with $280 million in commitments. The team is led by five investment partners: Kevin Bitterman, Bruce Booth, Jean-Francois Formela, David Grayzel, and Jason Rhodes.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles